Dermata Therapeutics Inc (DRMA) — Financial Flexibility Index
Dermata Therapeutics Inc (DRMA) has a Financial Flexibility Index of -1.26x as of June 2026. Free cash flow of $-2.31 Million (operating CF $-2.42 Million minus capex $110.67K) represents -1% of total liabilities ($1.83 Million). Check tangible equity quality of Dermata Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dermata Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Dermata Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see DRMA cash generation efficiency.
Annual Financial Flexibility Index for Dermata Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Dermata Therapeutics Inc. Explore DRMA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4728.93x | $-7.76 Billion | $-7.76 Billion | $1.64 Million | ▼ -83473.0% |
| 2024 | -5.66x | $-11.16 Million | $-11.16 Million | $1.97 Million | ▼ -43.3% |
| 2023 | -3.95x | $-6.41 Million | $-6.41 Million | $1.62 Million | ▲ +58.8% |
| 2022 | -9.57x | $-8.83 Million | $-8.83 Million | $922.63K | ▼ -155.1% |
| 2021 | -3.75x | $-5.69 Million | $-5.69 Million | $1.52 Million | ▼ -252.5% |
| 2020 | -1.06x | $-4.03 Million | $-4.03 Million | $3.78 Million | ▲ +38.2% |
| 2019 | -1.72x | $-3.92 Million | $-3.92 Million | $2.28 Million | — |